deltatrials
Terminated PHASE4 INTERVENTIONAL 2-arm NCT04223050

Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation (O2flow-COPD)

Will Titrated Oxygen Flow to a Peripheral Oxygen Saturation of 88-92% Compared With Oxygen Flow to a Saturation >94% Reduce Mortality in Chronic Obstructive Pulmonary Disease Patients With Acute Exacerbation? - a Randomized Clinical Trial

Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark

Conditions COPD Exacerbation Chronic Obstructive Pulmonary Disease Exacerbation
Interventions Oxygen gas
Updated 12 times since 2020 Last updated: Mar 9, 2026 Started: Feb 3, 2020 Primary completion: Aug 31, 2024 Completion: Aug 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Not possible to include patients at the required speed

Other terminated trials from Esbjerg Hospital - University Hospital of Southern Denmark

See all terminations from Esbjerg Hospital - University Hospital of Southern Denmark

Other COPD Exacerbation trials with similar outcome

Browse all COPD Exacerbation trials

A PHASE4 clinical study on COPD Exacerbation and Chronic Obstructive Pulmonary Disease Exacerbation, this trial is terminated or withdrawn. The trial is conducted by Esbjerg Hospital - University Hospital of Southern Denmark and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshotNot Yet Recruiting~Mar 2020 – ~Dec 2020 · 9 months · monthly snapshotRecruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Nov 2022 · 13 months · monthly snapshotRecruiting~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshotRecruiting~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotRecruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotRecruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotRecruiting~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshotRecruiting~Nov 2024 – ~Mar 2026 · 16 months · monthly snapshotUnknown~Mar 2026 – present · 5 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Mar 2026 — Present [monthly]

    Terminated PHASE4

    Status: Unknown → Terminated

  2. Nov 2024 — Mar 2026 [monthly]

    Unknown PHASE4

    Status: Recruiting → Unknown

  3. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE4

  4. Aug 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

  5. Jul 2024 — Aug 2024 [monthly]

    Recruiting PHASE4

▶ Show 7 earlier versions

  1. Dec 2022 — Jul 2024 [monthly]

    Recruiting PHASE4

  2. Nov 2022 — Dec 2022 [monthly]

    Recruiting PHASE4

  3. Oct 2021 — Nov 2022 [monthly]

    Recruiting PHASE4

  4. Jan 2021 — Oct 2021 [monthly]

    Recruiting PHASE4

  5. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  6. Mar 2020 — Dec 2020 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  7. Feb 2020 — Mar 2020 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Esbjerg Hospital - University Hospital of Southern Denmark
  • Holbaek Sygehus
  • Odense University Hospital
  • Sygehus Lillebaelt
Data source: Esbjerg Hospital - University Hospital of Southern Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations